These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 31618428)
21. [Differential diagnostic distinction between substance-induced and primary psychoses: : Recommendations for general psychiatric and forensic practice]. Hirjak D; Meyer-Lindenberg A; Brandt GA; Dreßing H Nervenarzt; 2022 Jan; 93(1):11-23. PubMed ID: 33656571 [TBL] [Abstract][Full Text] [Related]
22. [Cannabis and psychosis: search of a causal link through a critical and systematic review]. Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375 [TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review. Wilson L; Szigeti A; Kearney A; Clarke M Schizophr Res; 2018 Jul; 197():78-86. PubMed ID: 29117908 [TBL] [Abstract][Full Text] [Related]
24. Isosafrole and schizophrenia-like psychosis. Keitner GI; Sabaawi M; Haier RJ Am J Psychiatry; 1984 Aug; 141(8):997-8. PubMed ID: 6465379 [TBL] [Abstract][Full Text] [Related]
25. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness? Dalmau A; Bergman B; Brismar B Eur Psychiatry; 1999 Nov; 14(7):366-71. PubMed ID: 10683620 [TBL] [Abstract][Full Text] [Related]
27. Substance misuse and early psychosis. Tucker P Australas Psychiatry; 2009 Aug; 17(4):291-4. PubMed ID: 19301164 [TBL] [Abstract][Full Text] [Related]
28. Differences in associations between cannabis and stimulant disorders in first admission psychosis. Sara G; Burgess P; Malhi GS; Whiteford H; Hall W Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162 [TBL] [Abstract][Full Text] [Related]
29. [Differential diagnosis and syndrome-genetic problems and aspects of drug-induced psychoses in juveniles (author's transl)]. Bron B; Fröscher W; Gehlen W Fortschr Neurol Psychiatr Grenzgeb; 1976 Dec; 44(12):673-82. PubMed ID: 1051411 [TBL] [Abstract][Full Text] [Related]
30. Cannabis use and transition to psychosis in people at ultra-high risk. Valmaggia LR; Day FL; Jones C; Bissoli S; Pugh C; Hall D; Bhattacharyya S; Howes O; Stone J; Fusar-Poli P; Byrne M; McGuire PK Psychol Med; 2014 Sep; 44(12):2503-12. PubMed ID: 25055169 [TBL] [Abstract][Full Text] [Related]
33. Cannabis abuse and risk for psychosis in a prodromal sample. Kristensen K; Cadenhead KS Psychiatry Res; 2007 May; 151(1-2):151-4. PubMed ID: 17383738 [TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Marconi A; Di Forti M; Lewis CM; Murray RM; Vassos E Schizophr Bull; 2016 Sep; 42(5):1262-9. PubMed ID: 26884547 [TBL] [Abstract][Full Text] [Related]
35. Drug-induced psychosis. Abruzzi W Int J Addict; 1977 Feb; 12(1):183-93. PubMed ID: 863562 [No Abstract] [Full Text] [Related]
36. Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation. Sara GE; Large MM; Matheson SL; Burgess PM; Malhi GS; Whiteford HA; Hall WD Aust N Z J Psychiatry; 2015 Feb; 49(2):106-17. PubMed ID: 25518844 [TBL] [Abstract][Full Text] [Related]
37. Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis. McHugh MJ; McGorry PD; Yung AR; Lin A; Wood SJ; Hartmann JA; Nelson B Psychol Med; 2017 Mar; 47(4):616-626. PubMed ID: 27821204 [TBL] [Abstract][Full Text] [Related]